Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

More than 200 Poles Sickened by 'Designer Drugs'

July 15, 2015 8:40 am | by The Associated Press | News | Comments

The drugs consist of powerful psychoactive substances sold as powders or ground leaves with warnings that they not be ingested, language that has so far allowed them to be sold in a legal gray zone. Read more...


Anti-hypertensive Therapeutics Market Value in Asia Pacific to Approach $20B by 2021

July 15, 2015 8:40 am | by Aswini Nath, Analyst, GBI Research | Articles | Comments

Japan is the largest anti-hypertensive therapy market among the four APAC countries, valued at $8.1 billion in 2014 and representing 52 percent of the region’s anti-hypertensive treatment space. Read more...


J&J Tops Street 2Q Forecasts

July 14, 2015 12:16 pm | by Linda A. Johnson, AP Business Writer | News | Comments

Restrained spending and a sizeable one-time gain helped health giant Johnson & Johnson post a 4.4 percent increase in second-quarter profit, despite lower sales in all three business segments and in every region as unfavorable currency exchange rates shaved revenue. Read more...


Treating More Adults with Statins Would Be Cost-Effective Way to Boost Heart Health

July 14, 2015 12:12 pm | by Harvard Public Health | News | Comments

A new study from Harvard T.H. Chan School of Public Health researchers has found that it would be cost-effective to treat 48-67% of all adults aged 40-75 in the U.S. with cholesterol-lowering statins. Read more...


Unilens Signs Definitive Agreement To Be Acquired By Valeant Pharmaceuticals

July 14, 2015 12:06 pm | News | Comments

Unilens Vision Inc. announced today that they have entered into a definitive agreement under which a subsidiary of Valeant Pharmaceuticals International, will acquire all of the outstanding common stock of Unilens Vision Inc. (Unilens) for $12.75 per share in cash, or a total enterprise value of approximately $28 million, which includes approximately $5 million in debt. Read more...


PhRMA, Epilepsy Foundation Report More Than 400 Neurological Disorder Medicines in Development

July 14, 2015 12:03 pm | News | Comments

America's biopharmaceutical research companies are currently developing 420 medicines for patients suffering from neurological disorders, including epilepsy, Alzheimer's disease, multiple sclerosis (MS) and Parkinson's disease. Read more...


ANI Acquires 22 Generic Drug Products from Teva for $25 million

July 14, 2015 11:55 am | News | Comments

ANI Pharmaceuticals, Inc. ("ANI") today announced that it has acquired 22 previously marketed generic drug products from Teva Pharmaceuticals for $25 million in cash and a percentage of future gross profits from product sales. Read more...


Study: Silent Cancer in Moms A Rare Result in Prenatal Tests

July 14, 2015 11:35 am | by By Lindsey Tanner, AP Medical Writer | News | Comments

For pregnant women, abnormal results from certain prenatal tests may signal that something is wrong - with the moms-to-be, not the fetus, a preliminary study suggests. Read more...


Hepatitis C Medications Found Cost-Effective by Panel

July 14, 2015 11:03 am | by Stephanie Guzowski, Editor | News | Comments

A panel comprised of physicians, health care workers and scientists have recommended that hepatitis C treatments with list prices of $1,000 per daily dose are cost-effective, according to a draft of their report obtained by Bloomberg Business. Read more...


Mylan One of First to Launch Generic Version of Namenda Tablets

July 14, 2015 9:02 am | News | Comments

Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment of moderate to severe dementia of the Alzheimer's type. Read more...


Soliris Could Drive Myasthenia Gravis Treatment Market Value Beyond $550M by 2024

July 14, 2015 8:55 am | by Melina Reisenberg, Ph.d., Neurology Analyst, GlobalData | Articles | Comments

Soliris is expected to launch in the US in 2018, followed by its entry in the five European countries (5EU) and Japan in 2019 and 2020, respectively. Read more...


Oxford Osteoarthritis Patients in New Clinical Trial

July 14, 2015 8:44 am | by University of Oxford | News | Comments

The trial will establish if a drug called methotrexate, commonly taken by people with rheumatoid arthritis, can also be effective in treating osteoarthritis: a completely different condition. Read more...


New Drug Combo Could Make Cancer More Sensitive to Chemo

July 14, 2015 8:43 am | by Cancer Research UK | News | Comments

These drugs are commonly used to treat several cancers – including breast, ovarian and prostate cancers. But not all cancers respond to them, and it’s difficult to predict which patients will benefit. Read more...


EU Drug Regulator Starts Safety Review of HPV Vaccines

July 14, 2015 8:41 am | by The Associated Press | News | Comments

Current HPV vaccine information doesn't include warnings about these conditions and no causal link has been found. Read more...


Streamlining Biologic Purification and Screening Workflow with Multi-D Chromatography

July 14, 2015 8:41 am | by Philip Chapman, Global Product Manager; Phillip Elms, Senior Scientist; Gunjan Choudhary, Technical Editor, of Bio-Rad Laboratories | Articles | Comments

Chromatography plays an important role in the screening of insoluble aggregates during biologics production. However, the need for multiple purification steps makes traditional workflows time -consuming and labor-intensive. Multidimensional chromatography overcomes these limitations through automation of the purification and screening workflows. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.